Vendor strategy and buy-versus-build leadership
Evaluated technology in the context of clinical need, economics, implementation, quality, and continuing service responsibility.
Enterprise technology, Diabetech, and Ultragenyx
Discipline · 6 records
Product strategy and operating leadership
Portfolio decisions, organizational design, commercial models, sourcing, partnerships, and continuing execution.
Global service delivery, device logistics, and participant support
Extended clinical technology delivery into site training, loaner devices, wireless connectivity, support, and operational accountability.
Ultragenyx · 2019–2024
HealthCordia: virtual diabetes disease-management operations
Extended connected glucose telemetry into payer- and employer-facing care programs with diagnostics, logistics, engagement, clinical workflows, and reporting.
Operating phase emphasized in career records: 2007–2012
Product strategy, portfolio decisions, and execution
Turned clinical and commercial needs into roadmaps, funded capabilities, delivery organizations, partner decisions, and measurable operating work.
Enterprise platforms, connected health, and Ultragenyx
Commercial strategy, payer models, and partnerships
Connected product capability with channels, partner economics, reimbursed services, and commercially workable delivery models.
1990s–present
Adaptive diabetes programs and the ACCESS / TEMPO context
Connects patient selection, intervention choices, devices, services, governance, and feedback into a care program that can adapt over time.
Historical operating experience; current design perspective in 2026